• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Atrial Fibrillation and Stroke in Patients with Hypertrophic Cardiomyopathy: Important New Insights.

作者信息

Borer Jeffrey S, Atar Dan, Marciniak Thomas, Kim Moo Hyun, Serebruany Victor

机构信息

The Howard Gilman Institute for Heart Valve Disease and the Schiavone Institute for Cardiovascular Research, State University of New York Downstate Medical Center, Brooklyn, New York, United States.

Division of Medicine, Department of Cardiology B, Oslo University Hospital and Institute of Clinical Sciences, University of Oslo, Oslo, Norway.

出版信息

Thromb Haemost. 2019 Mar;119(3):355-357. doi: 10.1055/s-0039-1678724. Epub 2019 Feb 13.

DOI:10.1055/s-0039-1678724
PMID:30759487
Abstract
摘要

相似文献

1
Atrial Fibrillation and Stroke in Patients with Hypertrophic Cardiomyopathy: Important New Insights.肥厚型心肌病患者的心房颤动与卒中：重要的新见解
Thromb Haemost. 2019 Mar;119(3):355-357. doi: 10.1055/s-0039-1678724. Epub 2019 Feb 13.
2
Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?心房颤动与肥厚型心肌病：该对谁进行抗凝治疗？
Clin Res Cardiol. 2015 Oct;104(10):799-802. doi: 10.1007/s00392-015-0876-6. Epub 2015 Jul 2.
3
To the Editor- Patients with atrial fibrillation with hypertrophic cardiomyopathy: Do we need new stroke risk stratification?致编辑——肥厚型心肌病合并心房颤动患者：我们是否需要新的卒中风险分层？
Heart Rhythm. 2019 Aug;16(8):e56. doi: 10.1016/j.hrthm.2019.04.006. Epub 2019 Apr 4.
4
Reply to the Editor- Patients with atrial fibrillation with hypertrophic cardiomyopathy: Do we need new stroke risk stratification?
Heart Rhythm. 2019 Aug;16(8):e56-e57. doi: 10.1016/j.hrthm.2019.04.001. Epub 2019 Apr 4.
5
Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病合并心房颤动患者的卒中风险分层
J Am Coll Cardiol. 2018 Nov 6;72(19):2409-2411. doi: 10.1016/j.jacc.2018.07.098.
6
Vitamin K antagonist use for all patients with hypertrophic cardiomyopathy and atrial fibrillation: analysis of the literature and guideline review.所有肥厚型心肌病合并心房颤动患者使用维生素K拮抗剂：文献分析与指南回顾
Future Cardiol. 2014 Mar;10(2):229-33. doi: 10.2217/fca.13.109.
7
Could direct oral anticoagulants be an alternative to vitamin K antagonists in patients with hypertrophic cardiomyopathy and atrial fibrillation?对于肥厚型心肌病合并心房颤动的患者，直接口服抗凝剂能否替代维生素K拮抗剂？
Int J Cardiol. 2018 Apr 1;256:39. doi: 10.1016/j.ijcard.2017.10.113.
8
Silent AF and Hypertrophic Stroke Risk: More Data, More Monitoring.隐匿性房颤与肥厚性中风风险：更多数据，更多监测。
J Cardiovasc Electrophysiol. 2016 Jul;27(7):785-7. doi: 10.1111/jce.13012. Epub 2016 Jun 14.
9
Hypertrophic cardiomyopathy: a real risk factor for stroke.肥厚型心肌病：中风的一个真正危险因素。
Scott Med J. 2012 Feb;57(1):60. doi: 10.1258/smj.2011.011280. Epub 2011 Dec 22.
10
Atrial fibrillation in hypertrophic cardiomyopathy: mechanisms, embolic risk and prognosis.肥厚型心肌病中的心房颤动：机制、栓塞风险及预后
Anadolu Kardiyol Derg. 2006 Dec;6 Suppl 2:40-3.

引用本文的文献

1
The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation.直接口服抗凝剂与维生素K拮抗剂相比在肥厚型心肌病合并心房颤动患者中的疗效和安全性。
Thromb J. 2024 Jan 2;22(1):2. doi: 10.1186/s12959-023-00562-8.
2
Metalloproteinases and Hypertrophic Cardiomyopathy: A Systematic Review.金属蛋白酶与肥厚型心肌病：系统综述
Biomolecules. 2023 Apr 11;13(4):665. doi: 10.3390/biom13040665.
3
New Era: Mavacamten for Obstructive Hypertrophic Cardiomyopathy.
新时代：美伐他汀治疗梗阻性肥厚型心肌病。
Cardiovasc Hematol Agents Med Chem. 2023;21(2):78-83. doi: 10.2174/1871525721666221019095218.
4
Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation.肥厚型心肌病患者即使无房颤病史，也会增加缺血性卒中风险。
Sci Rep. 2022 Sep 22;12(1):15785. doi: 10.1038/s41598-022-19895-x.
5
Thromboembolism in Patients with Hypertrophic Cardiomyopathy.肥厚型心肌病患者的血栓栓塞症。
Int J Med Sci. 2021 Jan 1;18(3):727-735. doi: 10.7150/ijms.50167. eCollection 2021.
6
Thromboembolic Outcomes of Different Anticoagulation Strategies for Patients with Atrial Fibrillation in the Setting of Hypertrophic Cardiomyopathy: A Systematic Review.肥厚型心肌病背景下房颤患者不同抗凝策略的血栓栓塞结局：一项系统评价
J Atr Fibrillation. 2019 Dec 31;12(4):2207. doi: 10.4022/jafib.2207. eCollection 2019 Dec.